The resting metabolic rate test (RMR) determines the amount of energy (calories) your body burns at rest. It is measured using a small, non-invasive, hand-held device called the MedGem, and FDA-approved medical device that may be covered by some insurance plans. This test helps accurately assess how well your metabolism is actually functioning.
This non-invasive test (BIA) can be performed in-office and used to more assess and track changes relating to body composition (lean body mass and body fat mass), hydration status, and overall cellular health. It can reflect how well your current workout plan is helping you to build muscle and lose body fat, even when the scale isn’t changing.
The Mediator-Release Test (MRT) is a blood test used to detect hidden inflammatory responses to foods and food chemicals, especially effective for irritable bowel syndrome, migraine sufferers, fibromyalgia, and a wide range of other food sensitivity-related health problems. It may be covered by some insurance plans.
This test is a blood and urine analysis that provides assessment of key nutrients such as Antioxidants, B Vitamins, Minerals, and Essential Fatty Acids. It also assesses protein metabolism as well as toxic mineral exposure. It is covered by most insurance companies.
Apolipoprotein E (Apo-E) is an essential protein for the metabolism of cholesterol and triglycerides. Identification of this gene type has important implications in the recommended treatment strategies for individual patients to help reduce cardiovascular disease risk. It can help determine one’s response to statin therapy, dietary fat intake, as well as other risk factors (smoking and alcohol consumption). Approximately 45% of the population carries one or more of the high-risk variants within the Apo-E gene. Most insurance companies cover this test.
Methylenetetrahydrofolate Reductase (MTHFR) is an enzyme responsible for the breakdown of homocysteine, a potentially toxic amino acid the body naturally produces, and is also involved in folate metabolism. If altered, it can increase risk for heart disease, stroke, thrombosis, and methotrexate toxicity for cancer therapy. This gene test can help determine recommendations for individualized treatment. Most insurance companies cover this test.
This is a comprehensive stool analysis test that delves into overall digestive wellness, including gut inflammation, pancreatic function, fat digestion and malabsorption, and microfloral balance.